BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18411416)

  • 21. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.
    Aster JC
    Int J Hematol; 2005 Nov; 82(4):295-301. PubMed ID: 16298817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.
    Shimizu D; Taki T; Utsunomiya A; Nakagawa H; Nomura K; Matsumoto Y; Nishida K; Horiike S; Taniwaki M
    Int J Hematol; 2007 Apr; 85(3):212-8. PubMed ID: 17483057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
    Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
    Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation.
    Miyamoto A; Lau R; Hein PW; Shipley JM; Weinmaster G
    J Biol Chem; 2006 Apr; 281(15):10089-97. PubMed ID: 16492672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
    Rodig SJ; Payne EG; Degar BA; Rollins B; Feldman AL; Jaffe ES; Androkites A; Silverman LB; Longtine JA; Kutok JL; Fleming MD; Aster JC
    Am J Hematol; 2008 Feb; 83(2):116-21. PubMed ID: 17874453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.
    Palomero T; Dominguez M; Ferrando AA
    Cell Cycle; 2008 Apr; 7(8):965-70. PubMed ID: 18414037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances on NOTCH signaling in T-ALL.
    Tzoneva G; Ferrando AA
    Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.
    Dail M; Li Q; McDaniel A; Wong J; Akagi K; Huang B; Kang HC; Kogan SC; Shokat K; Wolff L; Braun BS; Shannon K
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5106-11. PubMed ID: 20194733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of NOTCH1 signaling in T-ALL.
    Ferrando AA
    Hematology Am Soc Hematol Educ Program; 2009; ():353-61. PubMed ID: 20008221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).
    Yamamoto K; Nakamachi Y; Yakushijin K; Miyata Y; Okamura A; Kawano S; Matsuoka H; Minami H
    Eur J Haematol; 2013 Jan; 90(1):68-75. PubMed ID: 23033986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
    Sanchez-Martin M; Ferrando A
    Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
    Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
    Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
    Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
    J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.
    Thompson BJ; Buonamici S; Sulis ML; Palomero T; Vilimas T; Basso G; Ferrando A; Aifantis I
    J Exp Med; 2007 Aug; 204(8):1825-35. PubMed ID: 17646408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of NOTCH1 mutation in adult T-cell acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Liu J; Guo X; Qiao C; Wu YJ; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1403-8. PubMed ID: 24370020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
    Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
    Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.
    Kindler T; Cornejo MG; Scholl C; Liu J; Leeman DS; Haydu JE; Fröhling S; Lee BH; Gilliland DG
    Blood; 2008 Oct; 112(8):3373-82. PubMed ID: 18663146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
    Lee SH; Jeong EG; Yoo NJ; Lee SH
    APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular vesicle microRNAs contribute to Notch signaling pathway in T-cell acute lymphoblastic leukemia.
    Colangelo T; Panelli P; Mazzarelli F; Tamiro F; Melocchi V; De Santis E; Cuttano R; Palumbo O; Rossi G; Bianchi F; Giambra V
    Mol Cancer; 2022 Dec; 21(1):226. PubMed ID: 36550553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.